<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104493</article-id><article-id pub-id-type="doi">10.7554/eLife.104493</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Gut Microbes</subject></subj-group></article-categories><title-group><article-title>Regulating uric acid</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Hu</surname><given-names>Caihong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5445-4532</contrib-id><email>chhu@zju.edu.cn</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Caihong Hu</bold> is in the College of Animal Sciences, Zhejiang University, China</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00a2xv884</institution-id><institution>College of Animal Sciences, Zhejiang University</institution></institution-wrap><addr-line><named-content content-type="city">Hangzhou</named-content></addr-line><country>China</country></aff></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>11</day><month>11</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e104493</elocation-id><permissions><copyright-statement>© 2024, Hu</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Hu</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-104493-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.100068" id="ra1"/><abstract><p>Certain strains of a bacterium found in the gut of some animals, <italic>Lactobacillus plantarum</italic>, are able to counter hyperuricemia, a condition caused by high levels of uric acid in the blood.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hyperuricemia</kwd><kwd><italic>Lactobacillus plantarum</italic></kwd><kwd>purine</kwd><kwd>nucleoside hydrolase</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Certain strains of a bacterium found in the gut of some animals, <italic>Lactobacillus plantarum</italic>, are able to counter hyperuricemia, a condition caused by high levels of uric acid in the blood.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Fu Y, Luo XD, Li JZ, Mo QY, Wang X, Zhao Y, Zhang YM, Luo HT, Xia DY, Ma WQ, Chen JY, Wang LH, Deng QY, Ben L, Saleemi MK, Jiang XZ, Chen J, Miao K, Lin ZP, Zhang P, Ye H, Cao QY, Zhu YW, Yang L, Tu Q, Wang WC. 2024. Host-derived <italic>Lactobacillus plantarum</italic> alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides. <italic>eLife</italic> <bold>13</bold>:e100068. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.100068">10.7554/eLife.100068</ext-link>.</p></boxed-text><p>Improvements in the quality of life have led to an increase in the incidence of hyperuricemia, a medical condition that can lead to kidney stones and gout, with cases increasingly affecting younger individuals (<xref ref-type="bibr" rid="bib6">Johnson et al., 2018</xref>; <xref ref-type="bibr" rid="bib14">Zhang et al., 2019</xref>). Hyperuricemia – the presence of abnormally high levels of uric acid in the blood – arises from interactions between the liver, the kidneys and the gut, which has a role in removing uric acid from the body (<xref ref-type="bibr" rid="bib3">Dalbeth et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Niu et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">Yun et al., 2017</xref>). Studies indicate that gut microbes are crucial to uric acid metabolism, and interventions such as probiotics, prebiotics and fecal microbiota transplants can help reduce hyperuricemia by altering the gut microbiota (<xref ref-type="bibr" rid="bib1">Cao et al., 2022a</xref>; <xref ref-type="bibr" rid="bib11">Wang et al., 2022</xref>; <xref ref-type="bibr" rid="bib15">Zhao et al., 2022</xref>).</p><p>It has been shown that various strains of bacteria can alleviate hyperuricemia through two mechanisms: the direct hydrolysis of uric acid, and the hydrolase-mediated degradation of nucleosides that are the precursors of uric acid in the intestine. <italic>Limosilactobacillus fermentum</italic> JL-3 – a strain isolated from Chinese mud water – is capable of the hydrolysis of uric acid (<xref ref-type="bibr" rid="bib12">Wu et al., 2021</xref>), whereas various strains of <italic>Lactobacillus</italic>, a well-known genus of bacteria, reduce uric acid levels through the hydrolysis of nucleosides in the intestine: these strains include <italic>L. paracasei</italic> (X11; <xref ref-type="bibr" rid="bib2">Cao et al., 2022b</xref>) and strains of <italic>L. plantarum</italic> derived from Chinese sauerkraut (DM9218-A; <xref ref-type="bibr" rid="bib7">Li et al., 2014</xref>) and Chinese mustard (GKM3; <xref ref-type="bibr" rid="bib5">Hsu et al., 2019</xref>).</p><p>Recent studies have revealed that gene cloning can be used to identify specific hydrolases involved in the degradation of nucleosides for <italic>L. plantarum</italic> and <italic>L. aviarius</italic> (<xref ref-type="bibr" rid="bib9">Li et al., 2023b</xref>; <xref ref-type="bibr" rid="bib8">Li et al., 2023a</xref>). However, the precise mechanisms underlying the hydrolysis of the nucleoside precursors of uric acid have remained unclear. Now, in eLife, Wence Wang (South China Agricultural University), Qiang Tu (Shandong University) and colleagues – including Yang Fu as first author – report the results of in vitro studies and experiments on geese and mice that shed new light on the hydrolysis of these precursors (<xref ref-type="bibr" rid="bib4">Fu et al., 2024</xref>).</p><p>The team isolated a strain called <italic>L. plantarum</italic> SQ001 from geese with hyperuricemia, and a genome-wide analysis revealed the presence of four genes that code for nucleoside hydrolysis-related enzymes (iunH, yxjA, rihA, rihC). In vitro experiments revealed that one of these enzymes, iunH, effectively catalyzes the hydrolysis of nucleosides, such as inosine and guanosine, converting them to nucleobases, as evidenced by metabolomics analysis. The hydrolysis mechanism was further validated through experiments that involved knocking out the gene for iunH in <italic>L. plantarum</italic> SQ001, and expressing it in <italic>E. coli</italic>. Although nucleosides are hydrolyzed to produce nucleobases, the direct link between this process and the reduction of uric acid remains unclear, possibly due to the transport of nucleosides and nucleobases in the gut. It may be that the lower uptake of these substances reduces the synthesis and accumulation of uric acid.</p><p>The team validated the functionality of <italic>L. plantarum</italic> SQ001 by establishing models of hyperuricemia in both geese and mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>), and showed that this particular strain significantly enhanced the abundance of <italic>Lactobacillus</italic> in the gut of the host, which alleviated the symptoms of hyperuricemia by reducing the synthesis of uric acid and increasing its excretion. The fact that hyperuricemia was alleviated in mice may help with efforts to develop new ways to treat hyperuricemia and gout in humans.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic><bold>Lactobacillus plantarum</bold></italic> <bold>reduces uric acid synthesis through the hydrolysis of nucleosides.</bold></title><p>A strain of the bacterium <italic>L. plantarum</italic> was isolated from the large intestine of geese with hyperuricemia, a condition caused by the presence of abnormally high levels of uric acid in the blood (top left). In vitro experiments showed that the presence of the bacteria led to an increase in the degradation of nucleosides that are precursors of uric acid. Administering the bacteria to healthy geese and mice (top right) also led to a reduction in the levels of uric acid in the blood. Other experiments showed that <italic>L. plantarum</italic> absorbed the nucleosides, and that an enzyme called iunH broke down the nucleosides to produce nucleobases (bottom).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104493-fig1-v1.tif"/><attrib>Figure created with <ext-link ext-link-type="uri" xlink:href="https://www.figdraw.com">figdraw.com</ext-link>.</attrib></fig></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Bu</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Effect and potential mechanism of <italic>Lactobacillus plantarum</italic> Q7 on hyperuricemia in vitro and in vivo</article-title><source>Frontiers in Nutrition</source><volume>9</volume><elocation-id>954545</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2022.954545</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Hao</surname><given-names>H</given-names></name><name><surname>Bu</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title><italic>Lactobacillus paracasei</italic> X11 ameliorates hyperuricemia and modulates gut microbiota in mice</article-title><source>Frontiers in Immunology</source><volume>13</volume><elocation-id>940228</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2022.940228</pub-id><pub-id pub-id-type="pmid">35874662</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalbeth</surname><given-names>N</given-names></name><name><surname>Gosling</surname><given-names>AL</given-names></name><name><surname>Gaffo</surname><given-names>A</given-names></name><name><surname>Abhishek</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Gout</article-title><source>Lancet</source><volume>397</volume><fpage>1843</fpage><lpage>1855</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00569-9</pub-id><pub-id pub-id-type="pmid">33798500</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>XD</given-names></name><name><surname>Li</surname><given-names>JZ</given-names></name><name><surname>Mo</surname><given-names>QY</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Luo</surname><given-names>HT</given-names></name><name><surname>Xia</surname><given-names>DY</given-names></name><name><surname>Ma</surname><given-names>WQ</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><name><surname>Deng</surname><given-names>QY</given-names></name><name><surname>Ben</surname><given-names>L</given-names></name><name><surname>Saleemi</surname><given-names>MK</given-names></name><name><surname>Jiang</surname><given-names>XZ</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Miao</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>ZP</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>QY</given-names></name><name><surname>Zhu</surname><given-names>YW</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Tu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>WC</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Host-derived <italic>Lactobacillus plantarum</italic> alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides</article-title><source>eLife</source><volume>13</volume><elocation-id>e100068</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.100068</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CL</given-names></name><name><surname>Hou</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>CS</given-names></name><name><surname>Lin</surname><given-names>SW</given-names></name><name><surname>Jhou</surname><given-names>BY</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Antiobesity and uric acid-lowering effect of <italic>Lactobacillus plantarum</italic> GKM3 in high-fat-diet-induced obese rats</article-title><source>Journal of the American College of Nutrition</source><volume>38</volume><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1080/07315724.2019.1571454</pub-id><pub-id pub-id-type="pmid">30794474</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RJ</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Borghi</surname><given-names>C</given-names></name><name><surname>Chonchol</surname><given-names>MB</given-names></name><name><surname>Feldman</surname><given-names>D</given-names></name><name><surname>Lanaspa</surname><given-names>MA</given-names></name><name><surname>Merriman</surname><given-names>TR</given-names></name><name><surname>Moe</surname><given-names>OW</given-names></name><name><surname>Mount</surname><given-names>DB</given-names></name><name><surname>Sanchez Lozada</surname><given-names>LG</given-names></name><name><surname>Stahl</surname><given-names>E</given-names></name><name><surname>Weiner</surname><given-names>DE</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: Report of a scientific workshop organized by the National Kidney Foundation</article-title><source>American Journal of Kidney Diseases</source><volume>71</volume><fpage>851</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2017.12.009</pub-id><pub-id pub-id-type="pmid">29496260</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e105577</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0105577</pub-id><pub-id pub-id-type="pmid">25184445</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>R</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Zong</surname><given-names>M</given-names></name><name><surname>Van Bockstaele</surname><given-names>F</given-names></name><name><surname>Lou</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2023">2023a</year><article-title><italic>Lactiplantibacillus plantarum</italic> enables blood urate control in mice through degradation of nucleosides in gastrointestinal tract</article-title><source>Microbiome</source><volume>11</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-023-01605-y</pub-id><pub-id pub-id-type="pmid">37468996</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Teng Zhu La</surname><given-names>AL</given-names></name><name><surname>Lyu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023b</year><article-title>Quercetin-enriched <italic>Lactobacillus aviarius</italic> alleviates hyperuricemia by hydrolase-mediated degradation of purine nucleosides</article-title><source>Pharmacological Research</source><volume>196</volume><elocation-id>106928</elocation-id><pub-id pub-id-type="doi">10.1016/j.phrs.2023.106928</pub-id><pub-id pub-id-type="pmid">37717681</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>LH</given-names></name><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inhibition of 3,5,2’,4’-tetrahydroxychalcone on production of uric acid in hypoxanthine-induced hyperuricemic mice</article-title><source>Biological &amp; Pharmaceutical Bulletin</source><volume>41</volume><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1248/bpb.b17-00655</pub-id><pub-id pub-id-type="pmid">29093325</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Regenstein</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The gut microbiota as a target to control hyperuricemia pathogenesis: Potential mechanisms and therapeutic strategies</article-title><source>Critical Reviews in Food Science and Nutrition</source><volume>62</volume><fpage>3979</fpage><lpage>3989</lpage><pub-id pub-id-type="doi">10.1080/10408398.2021.1874287</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>R</given-names></name><name><surname>Kakade</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title><italic>Limosilactobacillus fermentum</italic> JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid</article-title><source>Gut Microbes</source><volume>13</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1080/19490976.2021.1897211</pub-id><pub-id pub-id-type="pmid">33764849</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intestinal tract is an important organ for lowering serum uric acid in rats</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0190194</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0190194</pub-id><pub-id pub-id-type="pmid">29267361</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Huangfu</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hyperuricemia and cardiovascular disease</article-title><source>Current Pharmaceutical Design</source><volume>25</volume><fpage>700</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.2174/1381612825666190408122557</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The potential of probiotics in the amelioration of hyperuricemia</article-title><source>Food &amp; Function</source><volume>13</volume><fpage>2394</fpage><lpage>2414</lpage><pub-id pub-id-type="doi">10.1039/D1FO03206B</pub-id></element-citation></ref></ref-list></back></article>